Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
24,450 total articles
Clearmind Medicine has announced the completion of treatment for all participants in the initial phase (Part A) of its ongoing FDA-regulated Phase I/II clinical trial evaluating CMND-100, a novel therapeutic for Alcohol Use Disorder. The company is analyzing data and plans to proceed to the next stage of clinical development, advancing its non-hall…
Verrica Pharmaceuticals announced dosing of the first U.S. patient in the COVE-3 Phase 3 clinical trial evaluating YCANTH® (VP-102) for common warts. With a global Phase 3 program ongoing, including its Japanese partner Torii Pharmaceutical, the company targets a significant market with no current FDA-approved treatments. Positive Phase 2 results a…
Outdoor Holding Company, operator of GunBroker.com, reported a 10.1% revenue increase and significant reduction in operating losses for Q4 and fiscal year 2026, driven by cost reductions, settlement of legacy legal matters, and platform investments including AI enhancements. Adjusted EBITDA more than doubled year-over-year, with improved gross marg…
Westport Fuel Systems Inc. announced a definitive agreement for a $10 million registered direct offering of common shares and a concurrent private placement of warrants priced at-the-market under Nasdaq rules. The company expects to use the net proceeds for working capital and general corporate purposes. If private placement warrants are exercised,…
LifeMD, a Nasdaq-listed virtual care provider, announced an exclusive telehealth co-marketing partnership with Antares Pharma to launch a direct-to-patient self-pay program for XYOSTED®, the FDA-approved once-weekly testosterone enanthate auto-injector. Launching in July 2026 across 37 states, the program offers virtual evaluation, diagnosis, and h…
Kandi Technologies Group, Inc. reports accelerated international expansion of its off-road vehicle business. The company's products are now available in 35 countries and regions, with focused growth in Africa, Southeast Asia, Latin America, and the Middle East through a dual strategy of order expansion and brand localization. Key new dealer partner…
Veea Inc., a NASDAQ-listed leader in AI-powered edge infrastructure, has promoted Greg Deisher to COO, Mark Tubinis to Executive VP, and appointed Thomas Latiolais as CMO. These leadership changes aim to accelerate revenue growth, strengthen operational execution, and drive global market expansion across enterprise, industrial, and AI-enabled secto…
Tyson Foods has launched three new flavors—Garlic & Herb, BBQ, and Harissa—for its Tyson Chicken Cups, following strong consumer reception and recognition as Product of the Year in the Protein Snack category. The new offerings cater to diverse consumer taste preferences, especially among Millennials and Gen Z, and reinforce Tyson's position in conv…
Refinity, a subsidiary of Innventure, Inc. (NASDAQ: INV), has secured an exclusive license from Pacific Northwest National Laboratory (PNNL) to commercialize catalyst technology that converts waste plastic-derived light olefins into distillate-range hydrocarbons suitable for sustainable aviation fuel (SAF), renewable diesel, and lubricants. The com…
AgEagle Aerial Systems Inc., operating as EagleNXT, announced an order for two eBee VISION ISR drones and three eBee TAC tactical mapping drones from a customer in the ASEAN region. These lightweight, rapidly deployable, and secure drones will enhance the customer's defense and operational capabilities. This deal highlights EagleNXT's expanding int…
BitFuFu Inc., a leading Bitcoin mining company listed on NASDAQ under ticker FUFU, has approved a $5 million share repurchase program to be executed over the next 24 months. The program reflects the company's confidence in its long-term growth prospects and aims to enhance shareholder value while maintaining financial flexibility to invest in expan…
Kustom Entertainment, Inc. announced record attendance exceeding 32,000 for its 30th anniversary Country Stampede Festival in Kansas. The company reported multiple ticket classes sold out, signaling strong consumer demand. Additionally, Kustom has partnered with Ruffin Properties to host multi-season music festivals at Gilley's Gambling Hall Park C…
Rezolve Ai announces its Reward platform is powering Everyday Cashback, a new Visa Card Linked Offers program launched by Mashreq bank in the UAE. This initiative allows Mashreq cardholders to receive up to 20% automated cashback at hundreds of merchants, utilizing AI-driven personalized offers. The launch expands Rezolve Ai's presence into payment…
NorthStar Earth & Space, a Canadian-based company specializing in Space Situational and Domain Awareness, has secured commercial services contracts worth over CAD$40 million with the Royal Canadian Air Force's 3 Canadian Space Division. This partnership aims to integrate NorthStar's space-based surveillance technology to improve Canada's mission re…
Aptorum Group Limited (NASDAQ: APM) announced a collaboration between DiamiR Biosciences and AlzLabs Precision Diagnostics to develop blood-based biomarker tests for Alzheimer’s disease. The focus is on protein and microRNA biomarkers such as p-Tau 217, amyloid 42/40, and neurofilament light to improve non-invasive diagnosis and monitoring of neuro…
Genius Group Limited (NYSE American: GNS) announced the purchase of over 6 million Class A Ordinary Shares in a privately negotiated deal, following a recent 6.6 million share buyback. These transactions contribute to the removal of 32.6 million shares from the company's issued capital within eight days, equating to 27% of the public float, aiming …
Kyverna Therapeutics has appointed Ritesh Srivastava as Chief Legal and Compliance Officer to support its advancement towards potential commercialization of its lead CAR T-cell therapy, miv-cel, targeting autoimmune diseases such as stiff person syndrome. The appointment strengthens the company's executive team as it plans to transition into a comm…
Lifetime Brands, Inc. reported the outcomes of its 2026 Annual Meeting of Stockholders, including director elections, ratification of Ernst & Young LLP as auditor, approval of 2025 executive compensation, and amendment to its Long-Term Incentive Plan. The company also declared a quarterly cash dividend of $0.0425 per share.
GrowGeneration Corp., a leading supplier of specialty products for controlled environment agriculture and commercial cultivation, announced that CEO Darren Lampert will present at the iAccess Alpha Virtual Best Ideas Summer Investment Conference on June 23, 2026. The company highlights its broad product offerings and business segments during this e…
Autonomix Medical announced successful preclinical development of a proprietary standalone neural sensing platform capable of detecting renal nerve activity and real-time changes following intervention. Built on the same technology as their pancreatic cancer pain program, this platform offers a capital-efficient path into cardiology, particularly r…
Hyperion DeFi, the first U.S. publicly listed DeFi company on Hyperliquid, announced a partnership with Blockdaemon to support Hyperliquid staking operations via the Kinetiq X Hyperion Validator. This collaboration aims to expand institutional access and infrastructure in the growing Hyperliquid decentralized trading ecosystem. The partnership enab…
Nasus Pharma Ltd., a clinical-stage pharmaceutical company specializing in intranasal powder drug delivery technology, announced its participation at the upcoming Zacks Life Sciences Investor Forum. The management will present their innovative intranasal products, including their needle-free epinephrine alternative NS002, and engage with investors …
Revolution Medicines announces that Steve Kelsey, President of Research and Development, will transition to a senior advisor role effective July 1, 2026, ahead of his planned retirement in January 2027. The company also reveals a new R&D leadership structure to ensure ongoing strategic execution. Kelsey has played a key role in advancing the compan…
Prime Medicine announced that the FDA has granted Regenerative Medicine Advanced Therapy (RMAT) designation to its investigational therapy PM359 for the treatment of p47phox-deficient chronic granulomatous disease (CGD). This designation, based on promising Phase 1/2 clinical data, enables early FDA engagement and expedited review pathways, reinfor…
Taysha Gene Therapies announced the completion of dosing in its REVEAL pivotal trial evaluating TSHA-102 for Rett syndrome and reported positive longer-term clinical data from earlier phases. The gene therapy showed durable, clinically meaningful functional gains with no treatment-related serious adverse events. The company plans to submit a Biolog…
